42
Participants
Start Date
July 2, 2021
Primary Completion Date
November 1, 2025
Study Completion Date
November 1, 2025
Abemaciclib
Given PO
Biopsy Procedure
Undergo tumor biopsy
Biospecimen Collection
Undergo collection of blood
Olaparib
Given PO
SUSPENDED
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
RECRUITING
Thomas Jefferson University Hospital, Philadelphia
RECRUITING
University of Virginia Cancer Center, Charlottesville
RECRUITING
Wake Forest University Health Sciences, Winston-Salem
ACTIVE_NOT_RECRUITING
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
ACTIVE_NOT_RECRUITING
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
ACTIVE_NOT_RECRUITING
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
ACTIVE_NOT_RECRUITING
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
RECRUITING
Vanderbilt University/Ingram Cancer Center, Nashville
RECRUITING
Ohio State University Comprehensive Cancer Center, Columbus
RECRUITING
Mayo Clinic in Rochester, Rochester
ACTIVE_NOT_RECRUITING
Northwestern University, Chicago
SUSPENDED
University of Kansas Cancer Center - Lee's Summit, Lee's Summit
SUSPENDED
University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City
SUSPENDED
University of Kansas Cancer Center - North, Kansas City
SUSPENDED
University of Kansas Cancer Center, Kansas City
RECRUITING
University of Kansas Clinical Research Center, Fairway
SUSPENDED
University of Kansas Hospital-Westwood Cancer Center, Westwood
SUSPENDED
University of Kansas Cancer Center-Overland Park, Overland Park
SUSPENDED
University of Kansas Hospital-Indian Creek Campus, Overland Park
RECRUITING
University of Oklahoma Health Sciences Center, Oklahoma City
ACTIVE_NOT_RECRUITING
Mayo Clinic Hospital in Arizona, Phoenix
RECRUITING
Mayo Clinic in Florida, Jacksonville
National Cancer Institute (NCI)
NIH